Yes, stage 4 cancer is metastatic cancer. The two terms describe the same thing: cancer that has spread from where it started to distant parts of the body. When doctors assign a stage 4 diagnosis, they are confirming that cancer cells have traveled beyond the original tumor and nearby lymph nodes to establish new growths in organs or tissues far from the primary site.
How Staging and Metastasis Connect
The most widely used cancer staging system is the TNM system. The T describes the size of the original tumor, the N describes whether nearby lymph nodes are involved, and the M describes whether the cancer has metastasized, meaning it has spread to distant parts of the body. An M1 designation means distant spread has been confirmed. A stage 4 classification requires that M1 designation. In other words, stage 4 and metastatic are two ways of expressing the same finding.
Cancer that has only reached nearby lymph nodes is considered regional spread, not distant metastasis. Regional spread can place a cancer at stage 2 or stage 3 depending on the specifics, but it does not qualify as stage 4. The distinction matters because distant spread involves cancer cells entering the bloodstream or lymphatic system and colonizing organs that may be far from where the cancer originated.
Where Stage 4 Cancers Typically Spread
Different cancers have preferred destinations. Breast cancer most commonly spreads to bone, brain, liver, and lung. Lung cancer favors the adrenal glands, bone, brain, liver, and the opposite lung. Colon cancer tends to travel to the liver, lungs, and the lining of the abdominal cavity (the peritoneum). Prostate cancer commonly reaches the adrenal glands, bone, liver, and lungs.
These patterns are not random. The blood supply leaving each organ follows specific routes, and cancer cells tend to lodge in the first capillary bed they encounter. A tumor that starts in the colon, for instance, drains blood directly to the liver, which is why the liver is the most common site for colorectal metastases. Regardless of where a metastasis lands, it is still made up of cells from the original cancer. Breast cancer that spreads to the liver is metastatic breast cancer, not liver cancer, and it responds to breast cancer treatments.
How Doctors Confirm Distant Spread
Confirming metastasis typically involves imaging. CT scans and bone scans have been standard tools for decades. PET-CT, which combines a nuclear medicine scan with a CT scan, is now the most common advanced imaging method. It uses a radioactive tracer that cancer cells absorb more readily than normal tissue, making even small deposits visible. For prostate cancer specifically, newer tracers that bind to a protein on prostate cancer cells have improved detection accuracy compared to conventional scans.
When imaging finds something suspicious, a biopsy of the new site often follows. This confirms that the cells match the original cancer and rules out an entirely separate cancer forming independently. Equivocal scan results can lead to additional rounds of imaging or biopsies, which is one reason newer, more precise tracers are valuable.
Not All Stage 4 Cancer Looks the Same
Stage 4 covers a wide spectrum. On one end, a person may have dozens of metastatic deposits scattered across multiple organs. On the other end is what doctors call oligometastatic disease: cancer that has spread, but only to a few locations, typically one to five tumors. Oligometastatic disease is a recognized subtype of stage 4 cancer, and it behaves differently. It tends to grow more slowly and is less likely to continue spreading. In some cases, treatment can lead to long-term remission or even a cure, particularly when surgeons can remove the metastases or targeted radiation can destroy them.
The timing of the diagnosis also varies. Some people are diagnosed with stage 4 cancer from the start, before any treatment has been attempted. This is called de novo metastatic cancer. In breast cancer, about 5% to 10% of metastatic cases are de novo, meaning the cancer had already spread by the time it was first detected. The remaining 90% to 95% of metastatic breast cancer cases are recurrent, meaning the person was initially treated for an earlier stage and the cancer later returned in a distant location.
How Biomarkers Refine the Picture
Modern staging goes beyond just measuring physical spread. Since 2018, the staging system for breast cancer has integrated biological markers into the stage assignment. Factors like hormone receptor status, a growth-promoting protein called HER2, tumor grade, and gene expression profiles all feed into a “prognostic stage” that can differ from the purely anatomical stage. A tumor with favorable biology might be downstaged, while one with aggressive features could be upstaged. This means two people with identical-looking tumors on imaging could receive different stage assignments based on the molecular behavior of their cancer cells.
This matters for treatment planning. A stage 4 cancer driven by a specific molecular target may respond well to drugs designed to block that target, changing the outlook considerably compared to a stage 4 cancer with no identifiable vulnerabilities.
Treatment Goals at Stage 4
For most stage 4 cancers, the primary treatment goal shifts from cure to control. Treatments aim to slow or stop cancer growth, shrink tumors, relieve symptoms, and extend life while preserving quality of life. This can involve chemotherapy, targeted therapies, immunotherapy, radiation to specific painful or dangerous metastases, or combinations of these.
There are exceptions. Oligometastatic disease, as mentioned, can sometimes be treated with curative intent using surgery or precisely focused radiation. Certain cancer types, like testicular cancer, can be curable even at stage 4 with aggressive chemotherapy. But for the majority of stage 4 solid tumors, treatment is ongoing and aims to keep the disease stable for as long as possible.
Blood Cancers Use Different Systems
The TNM system stages solid tumors like breast, lung, and colon cancers, but it does not apply to blood cancers. Leukemia and lymphoma do not form a single primary tumor that then spreads, so the concept of “metastasis” does not map onto them in the same way. Lymphomas use a separate staging system called the Lugano system. While lymphoma can be classified as stage 4 under that system (typically meaning it involves organs outside the lymphatic system, like bone marrow or liver), calling it “metastatic” would be technically inaccurate. The biology of how blood cancers spread is fundamentally different from how solid tumors metastasize.